Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2006

Conditions
Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
Interventions
DRUG

EC-MPS

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY